Meridian Wealth Advisors LLC boosted its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 1.6% in the course of the second quarter, HoldingsChannel.com stories. The fund owned 14,468 shares of the corporate’s inventory after buying a further 234 shares in the course of the interval. Meridian Wealth Advisors LLC’s holdings in Johnson & Johnson had been price $2,115,000 as of its most up-to-date submitting with the Securities & Trade Fee.
A variety of different hedge funds and different institutional traders additionally just lately purchased and offered shares of the inventory. Innealta Capital LLC acquired a brand new place in Johnson & Johnson in the course of the 2nd quarter valued at roughly $27,000. Christopher J. Hasenberg Inc purchased a brand new stake in Johnson & Johnson within the first quarter valued at $31,000. MFA Wealth Advisors LLC acquired a brand new place in shares of Johnson & Johnson in the course of the second quarter valued at $43,000. Vermillion & White Wealth Administration Group LLC purchased a brand new place in shares of Johnson & Johnson in the course of the fourth quarter price about $44,000. Lastly, Grayhawk Funding Methods Inc. elevated its holdings in shares of Johnson & Johnson by 528.6% within the 4th quarter. Grayhawk Funding Methods Inc. now owns 308 shares of the corporate’s inventory price $48,000 after buying a further 259 shares in the course of the interval. 69.55% of the inventory is at the moment owned by institutional traders and hedge funds.
Insiders Place Their Bets
In different Johnson & Johnson information, VP Robert J. Decker offered 5,635 shares of the agency’s inventory in a transaction dated Friday, August thirtieth. The shares had been offered at a median worth of $165.06, for a complete worth of $930,113.10. Following the completion of the transaction, the vp now instantly owns 18,973 shares within the firm, valued at $3,131,683.38. The sale was disclosed in a submitting with the SEC, which is accessible by this hyperlink. Company insiders personal 0.16% of the corporate’s inventory.
Johnson & Johnson Inventory Efficiency
NYSE:JNJ opened at $164.41 on Friday. The corporate has a present ratio of 1.07, a fast ratio of 0.85 and a debt-to-equity ratio of 0.44. The corporate has a 50-day shifting common of $157.57 and a 200-day shifting common of $153.83. Johnson & Johnson has a twelve month low of $143.13 and a twelve month excessive of $168.85. The agency has a market cap of $395.68 billion, a price-to-earnings ratio of 10.25, a price-to-earnings-growth ratio of two.73 and a beta of 0.52.
Johnson & Johnson (NYSE:JNJ – Get Free Report) final posted its quarterly earnings outcomes on Wednesday, July seventeenth. The corporate reported $2.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.71 by $0.11. Johnson & Johnson had a web margin of 46.34% and a return on fairness of 36.60%. The agency had income of $22.45 billion for the quarter, in comparison with analyst estimates of $22.33 billion. Throughout the identical quarter within the earlier yr, the enterprise posted $2.80 earnings per share. The agency’s quarterly income was up 4.3% in comparison with the identical quarter final yr. Analysts forecast that Johnson & Johnson will put up 10.02 earnings per share for the present fiscal yr.
Johnson & Johnson Proclaims Dividend
The enterprise additionally just lately declared a quarterly dividend, which might be paid on Tuesday, September tenth. Buyers of document on Tuesday, August twenty seventh might be paid a $1.24 dividend. The ex-dividend date is Tuesday, August twenty seventh. This represents a $4.96 dividend on an annualized foundation and a yield of three.02%. Johnson & Johnson’s dividend payout ratio is at the moment 30.92%.
Wall Road Analysts Forecast Progress
JNJ has been the topic of a number of latest analyst stories. Cantor Fitzgerald restated an “chubby” ranking and issued a $215.00 goal worth on shares of Johnson & Johnson in a analysis report on Tuesday. TD Securities lowered their worth goal on Johnson & Johnson from $195.00 to $185.00 in a analysis report on Thursday, July 18th. The Goldman Sachs Group lowered their goal worth on Johnson & Johnson from $160.00 to $155.00 and set a “impartial” ranking on the inventory in a analysis report on Friday, July nineteenth. Daiwa America lower Johnson & Johnson from a “strong-buy” ranking to a “maintain” ranking in a analysis observe on Tuesday, July twenty third. Lastly, Sanford C. Bernstein lifted their worth goal on shares of Johnson & Johnson from $161.00 to $171.00 in a analysis observe on Thursday, July 18th. Seven analysis analysts have rated the inventory with a maintain ranking and 7 have given a purchase ranking to the corporate’s inventory. In line with information from MarketBeat.com, the corporate presently has a consensus ranking of “Average Purchase” and a median worth goal of $173.21.
Examine Out Our Newest Evaluation on JNJ
Johnson & Johnson Profile
Johnson & Johnson, along with its subsidiaries, researches, develops, manufactures, and sells varied merchandise within the healthcare area worldwide. The corporate’s Progressive Drugs phase provides merchandise for varied therapeutic areas, similar to immunology, together with rheumatoid arthritis, psoriatic arthritis, inflammatory bowel illness, and psoriasis; infectious ailments comprising HIV/AIDS; neuroscience, consisting of temper issues, neurodegenerative issues, and schizophrenia; oncology, similar to prostate most cancers, hematologic malignancies, lung most cancers, and bladder most cancers; cardiovascular and metabolism, together with thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension by retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.
See Additionally
Need to see what different hedge funds are holding JNJ? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Free Report).
Obtain Information & Scores for Johnson & Johnson Each day – Enter your e mail tackle beneath to obtain a concise day by day abstract of the newest information and analysts’ scores for Johnson & Johnson and associated firms with MarketBeat.com’s FREE day by day e mail publication.